what are the serious side effects of glp 1 Adverse GLP-1 class drugs. Gastrointestinal issues GLP-1 Medications: What You Need

Correlation between mild traumatic brain injury-induced inflammatory cytokines and emotional symptom traits: a systematic review

What We Saw in Phase 2 In earlier phase two trials, some key weight loss numbers were: Up to 10.1% weight reduction at 26 weeks in adults with type 2 diabetes, and up to 14.7% Weight Reduction at 36 Weeks in Adults with Obesity

insurer, Medicare, does not cover weight-loss drugs, making it tougher for older people to get access to promising new medications

Tesamorelin is studied as a GHRH analog with relevance to pituitary-axis signaling, GH release models, IGF-1 pathway activity, and metabolic regulation